Allogeneic double-negative T cell therapy for relapsed acute myeloid leukemia patients post allogeneic hematopoietic stem cell transplantation: A first-in-human phase I study.
Tang B, Lee JB, Cheng S, Pan T, Yao W, Wang D, Tu M, Xiang Z, Chu X, Geng L, Qiang P, Teng P, Sun G, Liu H, Wang J, Schimmer AD, Yang L, Sun Z, Zhang L, Zhu X.
Tang B, et al.
Am J Hematol. 2022 Jul;97(7):E264-E267. doi: 10.1002/ajh.26564. Epub 2022 Apr 16.
Am J Hematol. 2022.
PMID: 35385187
Free article.
Clinical Trial.
No abstract available.